Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Cubist outlines development plans for daptomycin

Feb. 18, 1998

SKB and WHO join forces to wipe out lymphatic filariasis

Feb. 18, 1998

Patients sought for GS-4104 clinical study

Feb. 17, 1998

Amphocil marketing agreement signed for Mexico

Feb. 16, 1998

Imiquimod for selftreatment of external anogenital warts

Feb. 16, 1998

Micrologix, PENCE to collaborate on new antibiotics

Feb. 12, 1998

Synercid scheduled for FDA committee review next week

Feb. 12, 1998

Roche develops orally active anti-HSV agent that targets viral TK

Feb. 12, 1998

Zeneca's new antibacterial agents active against resistant pathogens

Feb. 12, 1998

Anti-Candida activity of voriconazole compared to other antifungal agents

Feb. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.